Pennant Group achieved significant growth in Q4 2025, with revenue increasing 53.2% year-over-year to $289.3 million. The company saw strong momentum in its Home Health and Hospice segment, driven by strategic acquisitions and organic growth, while the Senior Living segment showed steady improvement in occupancy and rates.

The Pennant Group achieved record-breaking performance in the third quarter of 2025, with total revenue reaching $229.0 million, a 26.8% increase year-over-year. The company reported GAAP diluted earnings per share of $0.17 and adjusted diluted earnings per share of $0.30. Net income was $6.1 million, while adjusted net income saw a substantial increase of 27.6% to $10.4 million. This strong performance was driven by growth in both Home Health and Hospice Services and Senior Living Services segments, along with key acquisitions.

The Pennant Group demonstrated robust performance in the second quarter of 2025, with total revenue increasing by 30.1% to $219.5 million and net income rising by 24.5% to $7.1 million. Both home health and hospice services and senior living segments contributed meaningfully to this growth, driven by increased admissions and improved revenue per occupied unit.

The Pennant Group, Inc. announced robust first quarter 2025 operating results, with total revenue reaching $209.8 million, a 33.7% increase year-over-year. GAAP diluted earnings per share stood at $0.22, while adjusted diluted earnings per share was $0.27, reflecting strong operational performance across its home health, hospice, and senior living segments.

The Pennant Group, Inc. announced robust operating results for the fourth quarter and fiscal year ended December 31, 2024. Total revenue for the fourth quarter increased by 29.4% to $188.9 million, and diluted GAAP earnings per share were $0.16. Adjusted diluted earnings per share for the quarter stood at $0.24, reflecting strong operational performance and strategic expansion.

The Pennant Group reported a strong third quarter with a 28.9% increase in total revenue compared to the prior year quarter. GAAP diluted earnings per share were $0.20, and adjusted diluted earnings per share were $0.26. The company is well-positioned for future growth with a healthy balance sheet.

Pennant Group reported a strong second quarter with a 27.6% increase in total revenue to $168.7 million, and a 103.4% increase in net income to $5.7 million. The company is updating its annual guidance based on sustainable momentum and accretive additions.

The Pennant Group reported a strong first quarter with a 24.1% increase in total revenue to $156.9 million and a 165.2% increase in net income to $4.9 million. The company experienced accelerated growth and margin improvement, with record setting performance in the home health and hospice segment and all-time high revenue in the senior living segment.

The Pennant Group, Inc. reported strong Q4 2023 results, with a 17.1% increase in revenue and a 25.2% increase in net income compared to the prior year quarter. The company's performance was driven by growth in both its home health and hospice services and senior living services segments.

The Pennant Group, Inc. announced its Q3 2023 operating results, with total revenue of $140.2 million, a 18.5% increase over the prior year quarter. GAAP diluted earnings per share was $0.15, and adjusted diluted earnings per share was $0.20. Net income for the quarter was $4.4 million, a 44.4% increase over the prior year quarter.

The Pennant Group, Inc. reported a strong second quarter in 2023, with a 13.7% increase in total revenue and a 204.5% increase in net income compared to the prior year quarter. The company's Home Health and Hospice Services segment and Senior Living Services segment both experienced revenue growth. The company is well-positioned to take advantage of an increasing number of attractive acquisition opportunities.

Pennant Group reported a revenue increase of 11.0% and net income increase of 82.4% compared to the prior year quarter. The company's leadership and acquisition pipelines are strong, and the first quarter performance puts them on track to meet 2023 expectations. Cash flow from operations was $9.0 million.

Pennant Group reported Q4 2022 results with a revenue of $124.7 million, a net income of $3.5 million, and adjusted diluted earnings per share of $0.18. The company's performance was driven by growth in both its Home Health and Hospice Services and Senior Living Services segments.

The Pennant Group reported a revenue of $118.4 million, a 5.7% increase year-over-year. Net income for the quarter was $4.8 million. The company also completed the acquisition of Ardent Hospice and Palliative Care and Kenosha Visiting Nurse Association.

The Pennant Group reported a GAAP diluted loss per share of $0.09 and adjusted diluted earnings per share of $0.14 for Q2 2022. Total revenue increased by 5.4% year-over-year to $116.3 million. The company reaffirmed its 2022 annual revenue guidance of $450 million to $460 million.

The Pennant Group, Inc. reported first quarter 2022 results with total revenue of $113.9 million, a 7.8% increase over the prior year quarter. GAAP diluted earnings per share were $0.03 and adjusted diluted earnings per share were $0.11. Net income for the quarter was $1.0 million.

Pennant Group's Q4 2021 results were impacted by COVID-19, but the home health and hospice segment showed strength. Strategic transactions were executed to reposition the senior living segment for better results in 2022.

Pennant Group's Q3 2021 results were negatively impacted by a sharp rise in COVID-19 cases and ongoing labor challenges. Total adjusted revenue reached $111.9 million, with $79.0 million from Home Health and Hospice and $32.9 million from Senior Living. Net income was $1.2 million, with earnings per diluted share of $0.04 and adjusted earnings per diluted share of $0.11.